Harmony Biosciences

$29.08
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.62 (+2.18%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell HRMY and other stocks, options, and ETFs commission-free!

About HRMY

Harmony Biosciences Holdings, Inc. Common Stock, also called Harmony Biosciences, is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders.

CEO
John C.s Jacobs
Employees
150
Headquarters
Plymouth Meeting, Pennsylvania
Founded
2017
Market Cap
1.63B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
214.69K
High Today
$29.33
Low Today
$28.56
Open Price
$28.60
Volume
60.36K
52 Week High
$52.74
52 Week Low
$26.51

HRMY Earnings

-$0.14
-$0.01
$0.12
$0.25
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
$0.09 per share
Actual
$0.25 per share
Replay Earnings Call

You May Also Like

CMI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure